Executive Summary
The 40 filings for June 17, 2026, reveal a period of significant leadership turnover and strategic realignment across US equities, with a notable concentration of CFO transitions (Alaska Air, AMC Networks, Innodata, Certara, CONMED) and board refreshments.
A key positive theme is the prevalence of planned, orderly successions, often promoting internal talent (e.g., CME Group, Tennant Co, Alaska Air), which signals strong governance and strategic continuity. However, several filings reveal shareholder dissent on equity compensation plans (Ardelyx, Magnachip, Acrivon, SeaStar Medical), indicating growing investor pushback on dilution. The most actionable data comes from Progressive, which reported a 36% surge in net income and a 4.8-point improvement in its combined ratio, a standout operational performance. Conversely, the CFO resignation at Certara, despite reaffirmed guidance, introduces execution risk. The data shows a clear sector pattern: industrial and tech firms are leveraging performance-based equity to retain key talent, while consumer-facing firms are managing orderly executive departures. The overall sentiment is cautiously positive, with the market rewarding clear succession planning and penalizing governance opacity.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from June 10, 2026.
Investment Signals (10)
- Progressive Corp ↓ (BULLISH)▲
Reported a 36% YoY surge in net income to $1,445M and a 4.8-point improvement in combined ratio to 82.1, with net premiums written up 6% YoY. This exceptional underwriting performance signals strong pricing power and operational efficiency
- CME Group ↓ (BULLISH)▲
Announced a planned CEO succession with President/CFO Lynne Fitzpatrick becoming CEO in March 2027, under a leader who has driven an 8,000% market cap increase to $95B. This orderly transition signals stability and a deep bench
- Innodata ↓ (BULLISH)▲
Appointed a new CFO while reaffirming full-year 2026 revenue growth guidance of ~40% YoY (raised from 35%), with quarterly revenue now exceeding total annual revenue from three years ago. This signals accelerating growth and strong execution
- Bloom Energy ↓ (BULLISH)▲
Granted CEO Dr. KR Sridhar a performance-based PSU award tied to total revenue targets through 2029, with a retention requirement until end of 2031. This aligns management with long-term growth as market cap surged from $5B to $79B
- Ardelyx ↓ (BEARISH)▲
Equity Plan Amendment passed with only 52.6% of votes cast in favor, indicating significant shareholder opposition to dilution. This signals potential governance friction and future compensation constraints
- Certara ↓ (BEARISH)▲
CFO John Gallagher will resign effective July 14, 2026, with only an internal interim CFO named. Despite reaffirmed guidance, the sudden departure of a key financial leader introduces execution risk
- Alaska Air Group ↓ (BULLISH)▲
Promoted CFO Shane Tackett to additional role of President, expanding his oversight to commercial operations. This internal promotion leverages 25+ years of tenure and signals strong alignment with the Hawaiian Airlines integration strategy
- Republic Airways ↓ (NEUTRAL)▲
New CEO Matthew Koscal appointed with predecessor receiving a $3.7M accelerated payout and 311,802 shares. This clean break and fresh leadership could signal a new strategic direction, but the high cost of transition is a watch item
- Latch Inc ↓ (NEUTRAL)▲
Granted 968,179 RSUs to CEO Dave Lillis, with 887,497 vesting immediately due to retroactive commencement. This large, immediate equity grant signals strong retention but also significant dilution for existing shareholders
-
Appointed John Gallagher as CFO, who is leaving the same role at Certara. This poaching of a CFO from another firm in the same digest signals a competitive talent market for financial leadership [BULLISH for CONMED, BEARISH for Certara]
Risk Flags (10)
- Certara/CFO Departure↓ [HIGH RISK]▼
CFO resignation effective July 14, 2026, with only an interim CFO appointed. The lack of a permanent successor creates uncertainty around financial strategy and investor relations, despite reaffirmed 2026 guidance
- Ardelyx/Shareholder Dissent↓ [HIGH RISK]▼
The Equity Plan Amendment passed with a razor-thin 52.6% approval, with 69.7M votes against. This level of opposition signals deep shareholder concern over dilution and could lead to proxy fights or compensation constraints
- SeaStar Medical/Governance Risk↓ [MEDIUM RISK]▼
The Omnibus Incentive Plan amendment faced significant opposition (223,813 votes against vs 551,233 for), with 1.4M broker non-votes. This, combined with a small shareholder base, indicates potential governance instability
- ProtoKinetix/Financial Reporting Lapses↓ [HIGH RISK]▼
The company disclosed late filings of its 2025 10-K and 2026 Q1 10-Q, alongside a board-approved repricing of options at lower exercise prices. This combination signals potential financial distress or operational challenges
- New Fortress Energy/Reverse Stock Split↓ [HIGH RISK]▼
Shareholders approved a 1-for-50 reverse stock split, a drastic measure often taken to avoid delisting. While part of a broader restructuring, this signals a severely depressed stock price and potential equity value destruction
- Twilio Inc/Lack of Transparency↓ [MEDIUM RISK]▼
The 8-K disclosed an officer change under Item 5.02 but provided no details on the officer, reason, or succession plan. This opacity can signal internal instability or governance issues
- Clorox/Undisclosed Departure↓ [MEDIUM RISK]▼
Similar to Twilio, an officer resignation was disclosed without specifics. The lack of detail on a senior departure is a governance red flag, potentially indicating a contentious exit
- LFTD Partners/Board Resignation↓ [LOW RISK]▼
Director Richard Morrissy resigned due to health concerns, but the immediate effective date and lack of a replacement create a sudden governance gap
- Progressive/Commercial Lines Stagnation↓ [MEDIUM RISK]▼
While Personal Auto is strong, Commercial Lines net premiums earned showed 0% YoY growth, and Property Lines premiums written declined 3% YoY year-to-date. This indicates a two-speed business model with a weak spot
- Acrivon Therapeutics/Equity Plan Opposition↓ [MEDIUM RISK]▼
The equity plan amendment received 3.8M votes against and 6.9M broker non-votes, indicating notable shareholder dissent on dilution for a pre-commercial biotech
Opportunities (10)
- Progressive Corp/Underwriting Momentum↓ (OPPORTUNITY)◆
With a combined ratio of 82.1 (improving 4.8 points YoY) and net income up 36%, the company is in a 'hard market' sweet spot. Continued favorable prior-year development ($226M) suggests reserve redundancies, providing a buffer for future earnings
- Innodata/Growth Trajectory↓ (OPPORTUNITY)◆
Reaffirmed ~40% YoY revenue growth guidance (raised from 35%) and quarterly revenue exceeding total annual revenue from three years ago. The new CFO from Mphasis brings M&A expertise, potentially accelerating growth
- Bloom Energy/CEO Alignment↓ (OPPORTUNITY)◆
The new PSU grant ties CEO compensation to total revenue targets through 2029, with a mandatory holding period until 2031. This extreme long-term alignment, combined with a market cap surge from $5B to $79B, signals high management confidence in future growth
- CME Group/Succession Clarity↓ (OPPORTUNITY)◆
The planned CEO transition to an internal candidate (Lynne Fitzpatrick) with deep company knowledge removes a key overhang. The 8,000% market cap growth under the outgoing CEO provides a strong foundation for continuity
- Alaska Air Group/Integration Synergy↓ (OPPORTUNITY)◆
Promoting CFO to President with expanded commercial oversight directly aligns financial discipline with the Hawaiian Airlines integration. This structure could accelerate cost synergies and revenue growth from the merger
- Visteon Corp/Strategic Board Addition↓ (OPPORTUNITY)◆
Appointing a former NVIDIA automotive leader (Gary Hicok) to the board and Technology Committee positions the company to capitalize on AI and autonomous driving trends, leveraging his 25 years of industry experience
- CONMED Corp/CFO Upgrade↓ (OPPORTUNITY)◆
Hiring John Gallagher, who has CFO experience at both Certara and BD, brings deep med-tech and public company expertise. His departure from a competitor could signal a strategic upgrade for CONMED
- nVent Electric/Undisclosed Change↓ (OPPORTUNITY)◆
While the filing lacks details, the very low materiality (1/10) and lack of negative sentiment suggest a routine, non-disruptive change. If it is a promotion, it could be a positive signal for internal talent development
- Tennant Co/Operational Consolidation↓ (OPPORTUNITY)◆
Promoting a 16-year veteran to COO with oversight of R&D, supply chain, and global business units signals a focus on operational efficiency. This could drive margin improvement in a $1.2B revenue business
- Elauwit Connection/Growth Phase Leadership↓ (OPPORTUNITY)◆
Appointing a new CIO/COO with experience scaling operations (World Cinema serves 8,000+ properties) as the company moves past its IPO phase signals a focus on operational maturity and growth
Sector Themes (6)
- CFO Musical Chairs◆
Three CFO transitions were noted across the filings (Certara, CONMED, Innodata), with John Gallagher moving directly from Certara to CONMED. This indicates a highly competitive market for financial leadership, particularly in the med-tech and industrial sectors, and can signal strategic shifts at both the losing and gaining firms.
- Shareholder Pushback on Equity Dilution◆
Multiple companies (Ardelyx at 52.6% approval, Magnachip at 73.5%, SeaStar Medical, Acrivon) faced notable opposition to equity plan amendments. This is a clear signal that institutional investors are scrutinizing dilution more closely, particularly at pre-commercial or underperforming companies.
- Orderly CEO Succession as a Positive Signal◆
CME Group, Alaska Air, and Republic Airways all announced planned, orderly CEO or President transitions with clear timelines and internal candidates. This pattern suggests strong corporate governance and is generally viewed positively by markets as it reduces uncertainty.
- Performance-Based Compensation as a Retention Tool◆
Bloom Energy, Comstock, and Latch Inc. all utilized performance-based or time-vesting equity awards with multi-year horizons (2029-2031). This trend reflects a shift toward tying executive pay to long-term operational metrics (revenue, stock price) rather than short-term earnings.
- Board Refreshment with Industry-Specific Expertise◆
Visteon (NVIDIA), Publix (CarMax/KPMG), and General Enterprise Ventures (construction) appointed directors with deep, relevant industry experience. This pattern shows boards are prioritizing domain expertise over generalist directors to navigate specific strategic challenges (AI, supply chain, real estate).
- Biotech Governance Under Scrutiny◆
Several biotech firms (Acrivon, Inmune Bio, SeaStar Medical, Ardelyx) saw significant shareholder dissent on equity plans. This suggests that investors in the high-dilution biotech sector are becoming more assertive in demanding compensation discipline, especially for pre-revenue companies.
Watch List (8)
-
Watch for the appointment of a permanent CFO. The quality and background of the successor will be a key signal of the company's strategic direction. The interim CFO, Faiz Mohammed, has been with the firm since 2018, providing some stability.
-
Given the strong May results (net income +36%, combined ratio 82.1), watch for continued momentum in June. Any deceleration in premium growth or deterioration in the combined ratio would be a key signal for the P&C cycle.
-
The CEO's PSUs are tied to total revenue targets through 2029. Watch for quarterly revenue reports to gauge progress toward these goals, which will be a direct indicator of management's ability to execute and earn their equity.
-
The approval of the reverse stock split and charter amendments is contingent on a Restructuring Transaction. Watch for details on this transaction, as it will determine the company's future capital structure and equity value.
-
The company must file its overdue 10-K and 10-Q to regain compliance. Failure to do so could lead to delisting or regulatory action, making this a critical near-term catalyst.
-
With 69.7M votes against the equity plan, watch for the company to engage with dissenting shareholders. Any changes to compensation strategy or board composition in response could be a positive governance signal.
-
The lack of transparency in the 8-K is a red flag. Watch for a subsequent filing or press release clarifying the officer change, which will be necessary to assess the materiality of the event.
-
With the 2025 Equity Incentive Plan amendment approved, watch for future equity grants to executives. The rate of share utilization will be a key indicator of future dilution for this early-stage biotech.
Filing Analyses
(40)
17-06-2026
Alaska Airlines promoted CFO Shane Tackett to the additional role of President, effective June 29, 2026. The expanded role adds the commercial organization to his existing finance and operations responsibilities, aiming to strengthen alignment and accelerate the Alaska Accelerate plan and Hawaiian Airlines integration. The filing does not include any negative or flat metrics, as it is a leadership appointment announcement.
- · Shane Tackett has been with Alaska Airlines for more than 25 years, holding leadership roles across financial planning, labor relations, revenue management, e-commerce and strategy.
- · Tackett became CFO in 2020 and has helped strengthen the company's balance sheet and shape the Hawaiian Airlines acquisition and integration.
- · The new role is effective June 29, 2026; Tackett will continue to report to CEO Ben Minicucci and serve on the Executive Committee.
- · The promotion follows prior leadership announcements in September 2025 for Diana Birkett Rakow, Andy Schneider, and Jason Berry, as well as recent promotions of Kyle Levine and Lindsay-Rae McIntrye.
17-06-2026
Acrivon Therapeutics held its 2026 annual meeting on June 17, 2026, where stockholders approved the Amended and Restated 2022 Equity Incentive Plan, increasing the share reserve by 3,000,000 shares to a total of 8,606,723 shares. Michael Tomsicek and Charles Baum were elected as Class I directors. The ratification of PricewaterhouseCoopers LLP as independent auditor was overwhelmingly approved with 31,278,962 votes in favor. However, the equity plan approval showed notable opposition, with 3,757,400 votes against and 6,928,436 broker non-votes, indicating some shareholder dissent.
- · The share reserve automatically increases on January 1 each year through 2032 by 5% of fully diluted shares outstanding on the preceding December 31, unless the Board determines a lesser increase.
- · The record date for the annual meeting was April 23, 2026.
- · The company is an emerging growth company and has not elected to use the extended transition period for complying with new or revised financial accounting standards.
- · The Amended and Restated 2022 Plan allows for incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance awards, and other stock-based awards.
17-06-2026
Magnachip Semiconductor held its 2026 Annual Meeting on June 11, 2026, where stockholders approved the Amended and Restated 2020 Equity and Incentive Compensation Plan, increasing authorized shares by 3,000,000, and ratified EY Han Young as independent auditor for FY2026. All four director nominees were elected, and the advisory vote on executive compensation passed. However, the equity plan approval received only 73.5% of votes cast in favor (excluding broker non-votes), and the say-on-pay vote had 15.9% against, indicating notable shareholder dissent.
- · Record date for the meeting was April 21, 2026.
- · Four directors were elected to serve until the 2027 Annual Meeting.
- · Proposal 3 (ratification of auditor) received 22,467,959 votes for, 1,175,489 against, and 688,942 abstained, with no broker non-votes.
- · The equity plan approval had 13,328,072 for, 4,058,795 against, and 153,629 abstained, plus 6,791,894 broker non-votes.
- · Say-on-pay vote: 14,602,034 for, 2,791,527 against, 146,935 abstained, plus 6,791,894 broker non-votes.
17-06-2026
Visteon Corporation appointed Gary Hicok to its board of directors effective July 1, 2026. Hicok brings deep semiconductor, AI, and automotive experience from nearly 25 years at NVIDIA, where he led the automotive business and advanced autonomous vehicle technologies. The company reported 2025 annual sales of approximately $3.77 billion and secured $7.4 billion in new business.
- · Hicok will serve on the Technology Committee of the board.
- · Hicok holds a Bachelor of Science in Electrical Engineering from Arizona State University and completed graduate coursework toward a Master of Science in Electrical Engineering.
- · Visteon operates in 17 countries with a global network of innovation centers and manufacturing facilities.
17-06-2026
Graham Corporation announced the appointment of Jonathan W. Painter as Chairman of the Board, effective June 15, 2026, following the retirement of Daniel J. Thoren as Executive Chairman and Director. Thoren will remain as a Strategic Advisor through June 2027. The leadership transition, initiated in February 2025, is now complete, with CEO Matthew J. Malone having delivered strong operational and financial performance over the past year.
- · Daniel J. Thoren transitioned from President and CEO to Executive Chairman in June 2025 before retiring.
- · The Board will return to seven directors from a temporary eight-member structure.
- · Jonathan W. Painter previously served as Chairman until June 2025 and then as Lead Independent Director.
- · Thoren will focus on business development initiatives as Strategic Advisor through June 2027.
17-06-2026
Insight Molecular Diagnostics Inc. (IMDX) held its 2026 Annual Meeting on June 11, 2026, where shareholders elected four directors, ratified CBIZ CPAs P.C. as auditor, approved executive compensation on a non-binding advisory basis, and approved an amendment to the 2018 Equity Incentive Plan to increase authorized shares by 1,750,000 to a total of 5,550,000. All proposals passed with strong shareholder support, with the lowest approval (Incentive Plan amendment) receiving 19,117,865 votes for and 122,829 against. The meeting had a quorum of 23,954,212 shares (74.19% of voting power).
- · The annual meeting was held virtually via live webcast.
- · Record date for the meeting was April 27, 2026.
- · Broker non-votes totaled 4,708,719 on director elections, say-on-pay, and the incentive plan amendment.
- · The ratification of the accounting firm received 23,949,191 votes for, with no broker non-votes.
- · The say-on-pay proposal received 19,199,697 votes for and 26,126 against.
- · The incentive plan amendment received 19,117,865 votes for and 122,829 against.
17-06-2026
On June 12, 2026, Optex Systems Holdings Inc. CFO and Secretary Karen Hawkins notified her resignation effective December 31, 2026, upon expiration of her current employment agreement. The company has begun a search for a replacement and may engage Hawkins as a consultant for transition support. The resignation is for personal reasons with no disagreements or issues related to company operations or accounting practices.
- · Resignation effective date: December 31, 2026
- · Company has commenced a search for a suitable replacement
- · Hawkins may be engaged as a consultant on an interim basis post-effective date
- · No disagreements between Hawkins and the company; departure not related to operations, policies, or accounting practices
17-06-2026
Space Exploration Technologies Corp. (SpaceX) appointed Roelof Botha as an independent Common Stock Director and Audit Committee member, effective June 16, 2026. Mr. Botha brings deep public company and audit committee experience from his roles at Sequoia Capital and as former CFO of PayPal. Notably, a family member of Mr. Botha has been employed at SpaceX since January 2025 with annual compensation exceeding $120,000, and the company's non-employee directors currently receive no cash or equity compensation for board service.
- · Roelof Botha has been with Sequoia Capital since 2003 and was a managing member of Sequoia Capital Operations, LLC from 2007 to 2025.
- · Botha previously served as CFO of PayPal, Inc. from 2000 to 2003.
- · He has served on the Stanford University Board of Trustees since 2024.
- · Botha holds a B.S. in Actuarial Science, Economics, and Statistics from the University of Cape Town and an M.B.A. from Stanford Graduate School of Business.
- · A family member of Mr. Botha has been employed at SpaceX since January 2025 in enterprise operations, with 2025 compensation exceeding $120,000 and generally commensurate with peers.
- · SpaceX non-employee directors currently receive no cash or equity compensation for board or committee service.
- · SpaceX will enter into an indemnification agreement with Mr. Botha using a form previously filed as Exhibit 10.1 to the company's June 3, 2026 S-1 registration statement.
17-06-2026
Inmune Bio, Inc. held its annual meeting on June 16, 2026, where stockholders approved the Third Amended and Restated 2021 Stock Incentive Plan, increasing authorized shares from 6,500,000 to 9,158,525 and adding an evergreen provision through 2031. Stockholders also ratified the appointment of CBIZ CPAs P.C. as independent auditor for FY2026 and elected all five director nominees. The plan amendment was approved by a relatively narrow margin (6,085,086 for vs. 2,775,224 against), with 8,501,317 broker non-votes, indicating mixed shareholder sentiment on equity dilution.
- · The Amended Plan includes an evergreen provision that will automatically increase the share reserve on the first trading day of each year from 2027 through 2031 by the lesser of 10% of outstanding shares on December 31 of the prior year or a board-determined smaller number.
- · The Plan will expire on the tenth anniversary of the Effective Date (stockholder approval date) unless terminated earlier by the Committee.
- · All five director nominees were elected with votes for ranging from 5,955,609 (J. Kelly Ganjei) to 7,508,310 (Scott Juda, JD).
- · Ratification of CBIZ CPAs P.C. as independent auditor passed overwhelmingly with 17,293,255 votes for and only 107,064 against.
- · The Company is not an emerging growth company as defined in Rule 405 of the Securities Act.
17-06-2026
On June 12, 2026, Latch, Inc.'s Compensation Committee adopted updated equity award agreements (RSU, stock option, common stock) under the 2021 Incentive Award Plan. Simultaneously, the Committee granted time-based RSUs to three executives: Dave Lillis (PEO, 968,179 RSUs, ~$193,636 grant-date fair value), Jeff Mayfield (PFO, 130,000 RSUs, ~$26,000), and Ryan Salmons (CPTO, 500,000 RSUs, ~$100,000). Notably, the majority of these RSUs were already vested on the grant date due to retroactive vesting commencement dates (e.g., 887,497 of Lillis' shares vested immediately), reflecting prior service while the company's S-8 registration was suspended; the unvested portions will vest quarterly over the remainder of a three-year period.
- · The Compensation Committee adopted updated forms of RSU agreement, stock option agreement, and common stock agreement under the 2021 Incentive Award Plan on June 12, 2026.
- · The updated agreements include revisions to settlement timing to comply with Section 409A short-term deferral exemption, expanded tax withholding methods including net share withholding, and additional post-termination settlement procedures.
- · The vesting commencement dates for the executive RSUs were set retroactively: July 13, 2023 (Lillis), September 5, 2023 (Mayfield), and December 31, 2024 (Salmons), to recognize service during a period when the company could not grant equity due to a suspended S-8 registration statement.
- · The unvested portion of the executive RSUs will vest in substantially equal quarterly installments over the remainder of a three-year vesting period from the respective commencement dates.
17-06-2026
Usio, Inc. disclosed in an 8-K filing that its Compensation Committee approved new annual base salaries for three executives, effective August 3, 2026. Chairman, President and CEO Louis Hoch will receive $995,000; Senior Vice President and Chief Accounting Officer Greg Carter will receive $325,000; and Senior Vice President and Chief Accounting Officer Michael White will receive $260,000. All executives remain eligible for equity grants, annual bonuses, and standard employee benefits.
- · The salary changes are effective August 3, 2026.
- · The Compensation Committee approved the salaries on June 11, 2026.
- · The filing includes amendments to employment agreements for all three executives (Exhibits 10.1, 10.2, 10.3).
- · No prior salary figures were provided for comparison, so no period-over-period changes can be calculated.
17-06-2026
AMC Global Media Inc. appointed Hozefa Lokhandwala as Executive Vice President and CFO effective June 16, 2026, with a minimum base salary of $750,000 and annual target bonus of 100% of salary. The company also entered into a new employment agreement with CAO Michael J. Sherin III through August 2029, with a base salary of $475,000 and target bonus of 45% of salary. At the annual meeting, all director nominees were elected, KPMG was ratified as auditor, and advisory say-on-pay and the stock plan for non-employee directors were approved.
- · CFO employment agreement expires June 30, 2029; CAO agreement expires August 15, 2029.
- · CFO severance: at least 2x (base salary + target bonus) if terminated without cause or for good reason; CAO severance: at least 1.5x (base salary + target bonus) if terminated without cause.
- · CFO non-compete extends 1 year post-termination if employment ends before expiration.
- · Class A director Carl E. Vogel received 5,853,965 votes for and 15,950,979 withheld — the only director with more withheld than for votes.
- · Advisory say-on-pay received 121,381,952 for, 15,219,121 against, and 47,951 abstain (with 5,599,838 broker non-votes).
- · Stock plan for non-employee directors received 132,943,297 for, 3,695,457 against, and 10,270 abstain (with 5,599,838 broker non-votes).
- · Ratification of KPMG as auditor passed with 142,138,711 for, 98,835 against, and 11,316 abstain.
17-06-2026
Miami International Holdings, Inc. (MIAX) announced the adoption of a new Senior Executive Annual Bonus Plan effective for performance periods starting January 1, 2026, as approved by the Compensation Committee on June 15, 2026. The plan covers executive officers and other designated employees, with awards based on achievement of performance metrics and payable in cash or common stock under the company's 2022 Equity Incentive Plan. No financial figures or performance metrics were disclosed in this filing.
- · The Bonus Plan is effective for performance periods beginning January 1, 2026.
- · The plan is administered by the Compensation Committee for executive officers and by the CEO for other participants.
- · Awards may be paid in cash or common stock under the company's 2022 Equity Incentive Plan.
- · Payments are subject to the company's clawback policy and applicable law.
- · The full text of the Bonus Plan is expected to be filed as an exhibit to the company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2026.
17-06-2026
The filing is an 8-K regarding an officer change at nVent Electric plc, but no specific officer name, position, reason, or effective date is disclosed in the provided summary. The filing references Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Without details on the nature of the change (appointment vs. resignation), the individual involved, or the reason, the materiality and governance implications cannot be assessed. No quantitative financial data, scheduled events, or insider transactions are mentioned.
- · Filing date: June 17, 2026
- · AccNo: 0001104659-26-075152
- · Size: 209 KB
- · Sector: not specified
17-06-2026
The filing reports an officer change at The Clorox Company, triggered by the resignation of an unspecified officer, and includes regulatory disclosures under Items 5.02, 7.01, and 9.01. No specific details about the departing officer, appointment, financial metrics, or scheduled events are provided. The absence of concrete data limits assessment of materiality and market impact.
17-06-2026
Twilio Inc. filed an 8-K on June 17, 2026, disclosing an officer change under Item 5.02, along with shareholder voting results (Item 5.07) and exhibits (Item 9.01). The filing indicates a leadership transition, but specific details on the position affected, reason for change, and appointment/resignation status are not disclosed. The filing also covers the submission of matters to a vote of security holders, suggesting routine governance updates. However, without explicit data on the officer's role, departure reason, or succession plan, the materiality and market impact remain uncertain.
- · Filing date: June 17, 2026 (AccNo: 0001447669-26-000055, size 780 KB)
- · Items disclosed: 5.02 (officer change), 5.07 (shareholder vote), 9.01 (exhibits)
- · No specific officer name, title, or reason for departure provided in the filing summary
- · No financial metrics, transaction values, or share counts mentioned
17-06-2026
New Fortress Energy Inc. (NFE) held its 2026 Annual Meeting on June 17, 2026, where stockholders approved the Amended and Restated 2019 Omnibus Incentive Plan, amendments to the Charter (including a 1-for-50 reverse stock split and removal of staggered board), and the election of two Class I directors (Charles M. Sledge and Katherine E. Wanner). All proposals passed with strong support, though broker non-votes were significant on several items. The Restructuring Transaction remains a key condition for the incentive plan and Charter amendments to become effective.
- · The Amended and Restated Incentive Plan removes the evergreen provision and caps Class A common stock reserve at 10% of outstanding shares post-Restructuring, plus shares from existing awards.
- · A new reserve of Series A Mandatorily Convertible Preferred Stock is set at 7% of authorized shares post-Restructuring, converting to Class A common stock on the three-year anniversary of the Restructuring Effective Date.
- · The plan term extends to the tenth anniversary of the Restructuring Effective Date.
- · Within 120 days of the Restructuring Effective Date, the Board will adopt the NFE MIP with the assistance of a compensation consultant.
- · All proposals passed with strong majorities; broker non-votes were present on most items except those related to board size increase and reverse stock split (which had no broker non-votes).
- · The proposal to adjourn the Annual Meeting was rendered moot and not presented.
17-06-2026
Innodata Inc. appointed Jayant Chauhan as CFO effective July 6, 2026, with Marissa Espineli transitioning to Chief Accounting Officer. The company reaffirmed its full-year 2026 revenue growth guidance of approximately 40% or more year-over-year. While the appointment signals leadership strengthening and continued growth, the company’s previous guidance was raised from 35% to 40%, reflecting improving yet still forward-looking expectations.
- · Jayant Chauhan brings more than two decades of finance experience, most recently as SVP M&A at Mphasis.
- · Interim CFO Marissa Espineli will transition to Chief Accounting Officer reporting to the new CFO.
- · Innodata's quarterly revenue last quarter exceeded total annual revenue from three years ago.
- · The guidance reaffirmation is from the May 7, 2026 earnings release, raising prior guidance of 35%+ to 40%+.
17-06-2026
On June 17, 2026, The Campbell's Company announced that Daniel L. Poland, Executive Vice President and Chief Enterprise Transformation Officer, will step down from his current role effective August 3, 2026. He will remain with the company to assist with the transition of his responsibilities until January 10, 2027. The filing does not provide any financial metrics or performance data.
- · Daniel L. Poland's departure is effective August 3, 2026.
- · He will assist with transition until January 10, 2027.
- · The filing is an 8-K under Item 5.02 regarding director/officer changes.
17-06-2026
Verra Mobility announced organizational changes, including the appointment of Stacey Moser as Chief Customer Officer effective immediately to unify customer-facing functions, and the planned departure of Jon Baldwin, EVP of Government Solutions, effective July 9, 2026. These changes aim to accelerate transformation, enhance customer focus, and create a more efficient operating model, but the filing does not provide financial metrics or period-over-period comparisons, making it a neutral event.
- · Jon Baldwin's departure is effective July 9, 2026, and he will remain to support transition.
- · T2 Systems will continue to operate independently under Lin Bo's leadership.
- · The Transformation Committee of the Board recommended these changes.
- · Centralized functions include HR, Finance, Legal, Government Relations, Engineering and Product Management, reporting directly to the CEO.
17-06-2026
Certara, Inc. announced that CFO John Gallagher will resign effective July 14, 2026, with a search underway for a successor. Faiz Mohammed, SVP of Finance and Treasurer, will serve as Interim CFO. The company reaffirmed its 2026 financial guidance provided on May 11, 2026, maintaining stability despite the leadership change.
- · The company has launched a search with a leading executive search firm for the next CFO.
- · Faiz Mohammed has been with Certara since 2018 and has over 25 years of finance experience.
- · The 2026 guidance was initially provided during the first quarter earnings call on May 11, 2026.
17-06-2026
At its 2026 Annual Meeting of Stockholders on June 17, 2026, Ascent Solar Technologies, Inc. stockholders approved an amendment to the 2023 Equity Incentive Plan, increasing the share reserve from 893,611 to 1,700,000 shares. Two Class A directors, Louis Berezovsky and Forrest Reynolds, were elected for three-year terms, and all other proposals—including ratification of the independent auditor (Haynie & Company), advisory approval of executive compensation, and a meeting adjournment—were also approved. The company disclosed no financial results or operational updates in this filing.
- · The meeting was adjourned with 5,155,334 votes in favor, 200,888 against, and 27,378 abstentions (no broker non-votes).
- · A significant number of broker non-votes (3,706,497) were present for Proposals 1, 3, and 4, indicating substantial shares held by brokers that did not vote on non-routine items.
- · Proposal 3 (equity plan amendment) received 1,514,926 votes in favor, but with 146,264 votes against it had the lowest percentage of support among voted items (approximately 90.3% for vs. 9.7% against).
- · The company did not provide any financial results, forward-looking guidance, or updates on operations or business developments in this filing.
17-06-2026
CitroTech Inc. (NYSE American: CITR) announced the resignations of directors Theodore Ralston and Jeffery Pomerantz effective June 12, 2026, with no dispute with management or the Board. The Board appointed Michael Feigin, a seasoned construction and real estate executive, to fill one of the two vacancies, effective June 17, 2026. A search is ongoing for the remaining vacant board position.
- · Michael Feigin, age 66, has over 35 years of leadership experience in construction and real estate.
- · Feigin currently serves as President and CEO of JLA Consulting Group, LLC (since September 2020).
- · He previously served as CEO of MFB Insurance Company, Inc. (Feb 2025 – Feb 2026) and as Executive Vice President and Chief Construction Officer of AvalonBay Communities, Inc. (June 2014 – March 2020).
- · Feigin holds a B.A. in Psychology from Yale University and a J.D. from Brooklyn Law School.
- · Feigin has been appointed to the Board’s audit committee and compensation committee, and will serve as chairman of the Nominating Committee.
- · The remaining vacant board position is still being searched for by the Nominating Committee.
17-06-2026
Publix Super Markets announced the election of Jill Livesay to its board of directors, effective July 1, 2026. Livesay brings over 30 years of financial and leadership experience from KPMG, Advance Auto Parts, and CarMax, and will succeed the retiring director. The company continues to operate over 1,400 stores and employ more than 260,000 associates, maintaining its position as the largest employee-owned company in the U.S.
- · Jill Livesay will retire from CarMax on July 31, 2026.
- · Publix operates 1,438 stores across eight states: Florida, Georgia, Alabama, Tennessee, South Carolina, North Carolina, Virginia, and Kentucky.
- · Livesay is a graduate of James Madison University with a bachelor's degree in business administration with a concentration in accounting.
- · Livesay worked at Advance Auto Parts for more than 21 years, ending as senior vice president, chief accounting officer, and controller.
17-06-2026
CONMED Corporation appointed John E. Gallagher as Chief Financial Officer, effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who stays in advisory capacity through November 2, 2026. He brings nearly three decades of financial experience from Certara, Cue Health, BD, GE, and Ford Motor Company. No financial performance data was included in this filing, so no period-over-period comparisons are available.
- · Mr. Gallagher most recently served as CFO of Certara, Inc. starting 2023, and prior to that CFO of Cue Health Inc. (2021–2023).
- · He spent 9 years at BD, joining as Corporate Treasurer in 2012, and later became SVP & CFO of BD's Medical Segment in 2018.
- · He also served in finance leadership roles at General Electric Company and Ford Motor Company.
- · Mr. Gallagher holds an MBA from University of Pittsburgh and a B.S. in Finance from Clemson University.
17-06-2026
Ardelyx, Inc. held its 2026 Annual Meeting on June 16, 2026, where stockholders approved the Second Amendment to the Amended and Restated 2014 Equity Incentive Award Plan, elected three Class III directors, and ratified Ernst & Young LLP as the independent auditor for fiscal year 2026. The Say-On-Pay proposal passed with 93.6% of votes cast in favor, and stockholders supported an annual Say-On-Pay frequency. However, the Equity Plan Amendment was narrowly approved with only 52.6% of votes cast in favor, indicating significant shareholder opposition.
- · The Equity Plan Amendment passed with 77,395,305 votes for, 69,720,789 against, and 674,708 abstentions, representing a narrow 52.6% approval of votes cast (excluding broker non-votes).
- · Say-On-Pay received 137,617,786 votes for, 9,413,395 against, and 759,621 abstentions (93.6% approval of votes cast).
- · Stockholders voted 141,539,889 for an annual Say-On-Pay frequency, with 671,451 for two years, 3,426,669 for three years, and 2,152,793 abstentions.
- · Ratification of Ernst & Young LLP passed overwhelmingly with 186,182,340 votes for, 2,012,970 against, and 1,012,640 abstentions.
- · Director elections: Robert Bazemore received 143,174,322 votes for and 4,616,480 withheld; Muna Bhanji received 121,228,081 for and 26,562,721 withheld; Richard Rodgers received 141,495,737 for and 6,295,065 withheld.
- · The Board intends to hold future advisory Say-On-Pay votes annually.
17-06-2026
Bloom Energy Corp's Board of Directors approved a performance-based restricted stock unit (PSU) grant of 271,076 target shares to CEO Dr. KR Sridhar on June 15, 2026. The award is designed to retain Dr. Sridhar beyond 2027 and aligns long-term incentives with total revenue targets over a multi-year period ending December 31, 2029, with a potential payout of up to 300% of target. The company's market capitalization grew from approximately $5B as of December 31, 2024 to approximately $79B as of June 15, 2026, reflecting exceptional recent performance, though the filing notes that the prior 2024 award targets have been exceeded, suggesting some of the earlier goals may have become less challenging relative to the current growth trajectory.
- · The 2026 Award is conditioned on achievement of objective total revenue targets measured over the four consecutive fiscal quarters with highest aggregate total revenue within the July 1, 2026 to December 31, 2029 period.
- · PSU vesting is also subject to Dr. Sridhar's continuous leadership through December 31, 2029, with limited exceptions.
- · Dr. Sridhar generally must hold net shares from vesting until December 31, 2031.
- · The 2024 Award was based on annual product revenue growth and non-GAAP product gross margin for fiscal years 2025, 2026, and 2027; the 2026 Award uses different metrics (aggregate total revenue) and is designed to drive complementary sustained performance.
- · The Board noted the 2024 Award targets have been exceeded given recent outperformance.
17-06-2026
Republic Airways Holdings Inc. appointed Matthew J. Koscal as a director and President/CEO effective June 15, 2026, succeeding David Grizzle who resumed his role as non-executive Chairman. Grizzle received an accelerated cash payout of $3,695,156 and 311,802 shares in exchange for a release agreement. Additionally, CFO Joseph P. Allman and COO Paul K. Kinstedt were promoted to Executive Vice President and each granted equity awards totaling $500,000.
- · Board size increased to seven directors with Koscal's appointment.
- · Grizzle's accelerated payout includes $685,914 base salary, $1,616,189 cash bonus, $582,387 cash from 2025 LTIs, 183,297 shares from 2025 LTIs, 128,505 shares from 2026 PSUs, $796,786 projected 2027 awards, and $13,880 health insurance payout.
- · Grizzle will not receive additional compensation as independent director through 2027 Annual Meeting, subject to annual review.
- · Allman and Kinstedt each received 12,557 RSUs vesting in equal annual increments on March 20, 2027, 2028, and 2029, and 12,557 PSUs with vesting based on 3-year cumulative Controllable Completion Factor (CCF) from Jan 1, 2026 to Dec 31, 2028.
- · PSU performance thresholds: Threshold (50%) at 99.40% CCF, Target (100%) at 99.60% CCF, Max (200%) at 99.80% CCF.
17-06-2026
Vistagen Therapeutics announced that directors Margaret FitzPatrick and Dr. Joanne Curley will not stand for re-election at the 2026 Annual Meeting, each serving until the end of their current terms. The departures are not due to any disagreement with the company, but represent a board refreshment event. No financial metrics or performance data were disclosed in this filing.
- · Margaret FitzPatrick notified the company on June 16, 2026; Dr. Joanne Curley notified on June 17, 2026.
- · Both directors will continue to serve until the end of their terms at the 2026 Annual Meeting.
- · No reason for the decision was provided in the filing, and no replacement directors were announced.
17-06-2026
Richard Morrissy resigned from the Board of Directors of LFTD Partners Inc. effective June 14, 2026, citing health concerns that limit his time and attention. The resignation was not due to any disagreement with the company regarding operations, policies, or management. The filing contains no financial data or performance metrics.
- · Resignation effective immediately as of June 14, 2026.
- · No disagreement with company operations, policies, practices, or management was cited.
- · Filing signed by CEO Gerard M. Jacobs on June 17, 2026.
17-06-2026
ProtoKinetix, Inc. announced several corporate changes on June 17, 2026, including the resignation of director Edward McDonough and the appointment of Michael Jones, Jason Lamp, and Dr. Keith Brunt as directors, with Dr. Brunt also appointed as president. The company disclosed the formation of a wholly owned subsidiary, SightPath Biotech LLC, to develop its PKX-001 molecule for dry-eye disease, with a patent valuation of approximately $253 million. However, the company also reported late filings of its 2025 10-K and 2026 Q1 10-Q, and the board approved repricing of options and warrants at a lower exercise price, indicating potential financial or operational challenges.
- · Edward McDonough resigned on March 31, 2026, with no disagreement related to operations, policies, or practices.
- · Michael Jones and Jason Lamp were appointed as directors on June 17, 2026; both are seasoned entrepreneurs and longtime stockholders.
- · Dr. Keith Brunt, age 47, was appointed director and president on June 17, 2026; he has a PhD in experimental medicine and has served as a Medical Science Advisor to the company since 2019.
- · The patent valuation of $253 million was supported by two independent studies (IQVIA May 2021 and Benoit & Cote March 2025).
- · The company filed late notifications for its 2025 10-K (March 31, 2026) and 2026 Q1 10-Q (May 15, 2026); both reports are still pending.
- · Options for 61,190,000 shares were repriced from $0.028 to $0.01 per share, with expiration extended from December 6, 2028 to December 6, 2030.
- · Warrants for 6,000,000 shares were repriced from $0.028 to $0.01 per share, with expiration extended from December 12, 2028 to December 12, 2030.
17-06-2026
On June 15, 2026, Comstock Inc.'s Compensation Committee approved equity awards under the 2026 Equity Incentive Plan, granting an aggregate of 1,961,986 performance stock units (PSUs) and 783,618 restricted stock units (RSUs) to employees and executive officers. The awards are heavily performance-based, with PSUs tied to stock price appreciation targets over three years and vesting no earlier than June 30, 2029, while RSUs vest in equal annual installments starting June 30, 2027. The CEO received 247,252 RSUs and 619,059 PSUs, the CFO received 121,597 RSUs and 304,449 PSUs, and the CAO received 36,838 RSUs and 92,234 PSUs.
- · The PSUs vest only upon achieving stock price performance targets set by the Compensation Committee over the next three anniversaries and continued employment through June 30, 2029.
- · RSUs vest in three equal annual installments beginning June 30, 2027, subject to continued service.
- · The grants represent approximately 37% of the shares authorized under the 2026 Equity Incentive Plan.
17-06-2026
Tennant Company announced the appointment of Richard H. (Rusty) Zay as Chief Operating Officer, effective July 1, 2026. Zay, currently Chief Commercial Officer and a company veteran since 2010, will oversee global customer-facing business units, supply chain, manufacturing, R&D, and marketing. The company reported 2025 sales of $1.20 billion and approximately 4,500 employees, with no negative or flat performance metrics disclosed in this filing.
- · Zay joined Tennant in June 2010 as Vice President, Global Marketing; promoted to Vice President of Americas Sales and Service in 2014; later served as Senior Vice President, Innovation & Technology before becoming Chief Commercial Officer.
- · Zay holds a Bachelor of Science in Management from Purdue University.
- · Zay serves as President and Secretary of the Association of American Cleaning Equipment Manufacturers and served on the Holy Family Catholic High School Board of Directors and Finance Committee.
- · Tennant Company was founded in 1870, headquartered in Eden Prairie, Minnesota, and sells products directly in more than 21 countries and through distributors in more than 100 countries.
17-06-2026
Elauwit Connection, Inc. (ELWT) announced the appointment of Nick Jones as Chief Information Officer and Chief Operating Officer, replacing Rick Alder who served through the IPO phase. Under Alder's tenure, the company expanded to 176 sites and nearly 40,000 units in 15 months, improved Google customer satisfaction to 4.4 stars, and increased one-touch call resolution from 70% to 87%. The leadership change is part of the company's growth strategy, though no specific forward guidance or financial impact was provided.
- · Nick Jones previously served as EVP and COO at World Cinema, Inc., which serves more than 8,000 properties and over 1 million rooms across more than 200 brands.
- · Jones also served as CEO of NJT, Inc and as a Network Engineer at Schlumberger, First Edge Sornson, and Castle Dental.
- · Rick Alder played an instrumental role in advancing the Company’s strategic objectives and strengthening operations through the IPO phase.
- · The company's Google customer satisfaction rating improved to 4.4 stars under Alder's tenure.
- · A comprehensive product catalog was produced, including introduction of new retail business products at multi-purpose properties.
17-06-2026
CME Group announced that CEO Terry Duffy will transition to Executive Chairman on March 1, 2027, with President and CFO Lynne Fitzpatrick succeeding him as CEO and joining the Board. The company highlighted its growth under Duffy's 25-year tenure, including a market cap increase of over 8,000% to more than $95 billion and average daily volume of 28.1 million contracts last year. The transition is planned and orderly, with no negative performance metrics reported.
- · Duffy joined CME as a runner in 1980, purchased a seat in 1981, and founded TDA Trading.
- · Fitzpatrick has been with CME since 2006, previously served as Deputy CFO and Managing Director of Corporate Development and Treasurer.
- · Duffy was inducted into the Futures Industry Hall of Fame in 2025.
- · Fitzpatrick holds a BA in economics from Brown University and an MBA from the University of Chicago Booth School of Business.
- · Duffy served on the Federal Retirement Thrift Investment Board from 2003 to 2013.
17-06-2026
Progressive reported strong May 2026 results with net premiums written up 6% YoY to $7,027M and net income surging 36% to $1,445M, driven by a 10% increase in net premiums earned and a favorable combined ratio improvement of 4.8 points to 82.1. However, the Commercial Lines business showed flat net premiums earned growth (0% YoY), and Property Lines premiums written declined 3% YoY year-to-date, with catastrophe losses of 1.6% in the month weighing on underwriting performance.
- · Total policies in force grew 8% YoY to 39.97 million, with Direct auto up 11% and Agency auto up 8%, but Property lines only grew 1%.
- · The company reported a calendar year actuarial adjustment of $113 million for May 2026, comprising $81 million favorable development from prior accident years and $32 million from the current accident year.
- · Total prior accident years development was $226 million favorable for the month.
- · Fixed-income portfolio book yield was 4.3% pretax annualized for May 2026, up from 4.1% in May 2025.
- · Debt-to-total capital ratio stood at 19.9% as of May 31, 2026.
- · Net unrealized pretax losses on fixed-maturity securities were $(901) million as of May 31, 2026, a decrease of $(1,049) million from December 2025.
- · The company repurchased 1,269,184 common shares at an average cost of $198.42 per share during May.
- · Net catastrophe loss ratio for May 2026 was 1.4% companywide, with Personal Lines Property having the highest at 11.5%.
- · Total comprehensive income for YTD May 2026 was $4,521 million, down from $5,492 million in the prior year due to a $(829) million decrease in other comprehensive income from fixed-maturity securities.
17-06-2026
National Rural Utilities Cooperative Finance Corp (CFC) announced the election of Brent McRae, age 66, as President of the Board of Directors, effective June 15, 2026. Mr. McRae brings extensive experience from his roles at McCone Electric Cooperative, Central Montana Electric Power Cooperative, and the Montana Electric Cooperatives’ Association, along with a background as a self-employed rancher. There are no financial figures or period-over-period comparisons in this filing.
- · Brent McRae has served as a director of McCone Electric Cooperative since 2009.
- · He served as an alternate director of Central Montana Electric Power Cooperative from March 2018 to March 2021.
- · He has been a director of the Montana Electric Cooperatives’ Association since 2011 and served as its board president from October 2013 to October 2021.
- · Mr. McRae has been a self-employed rancher since 1989.
17-06-2026
SeaStar Medical Holding Corp held its annual meeting on June 17, 2026, where stockholders approved an amendment to the 2022 Omnibus Incentive Plan, increasing authorized shares from 207,046 to 896,546, and ratified WithumSmith+Brown, PC as the independent auditor for FY2026. Director John Neuman was elected with 757,141 votes for and 23,212 against, while the plan amendment received 551,233 for and 223,813 against, indicating significant opposition.
- · The plan amendment faced notable opposition: 223,813 votes against vs. 551,233 for, with 10,136 abstentions and 1,395,732 broker non-votes.
- · Ratification of WithumSmith+Brown, PC as auditor passed overwhelmingly with 2,151,096 for and 22,746 against.
- · The adjournment proposal was approved with 2,035,262 for and 123,747 against.
- · Broker non-votes were 1,395,732 on both the director election and plan amendment proposals, indicating a significant portion of shares were not voted by brokers on those items.
17-06-2026
Madrigal Pharmaceuticals held its 2026 Annual Meeting on June 17, 2026, where stockholders approved the 2026 Stock Plan, the 2026 Employee Stock Purchase Plan, and ratified the appointment of PricewaterhouseCoopers as independent auditor. The Board also adopted a Nonqualified Deferred Compensation Plan effective August 1, 2026, and entered into a consulting agreement with Dr. Rebecca Taub, who will transition from employee to consultant effective July 1, 2026, receiving $100,000 annually. All director nominees were re-elected, and the say-on-pay proposal passed with strong support.
- · The 2026 Stock Plan and 2026 ESPP were approved by stockholders with 19,118,851 and 19,546,766 votes in favor, respectively.
- · The Nonqualified Deferred Compensation Plan allows employees to defer up to 60% of base salary and up to 95% of annual cash performance bonus; non-employee directors may defer all or a portion of cash fees and equity grants.
- · The Deferred Compensation Plan is effective August 1, 2026, and the Company does not currently intend to make discretionary contributions.
- · Dr. Taub's consulting agreement is effective July 1, 2026, and she will continue to serve as a Class II director receiving standard non-employee director compensation.
- · All three Class I director nominees were re-elected with strong support (e.g., Daniel J. Brennan received 19,469,200 votes for).
- · The say-on-pay proposal passed with 19,000,895 votes for, 561,058 against, and 29,031 abstentions.
- · Ratification of PricewaterhouseCoopers as auditor received 21,256,315 votes for, 37,505 against, and 29,009 abstentions.
17-06-2026
ImageneBio, Inc. held its 2026 Annual Meeting on June 16, 2026, where stockholders approved an amendment to the 2025 Equity Incentive Plan, increasing authorized shares by 850,000, and elected two Class II directors (David P. Bonita, M.D. and Joseph P. Slattery) with overwhelming support (over 99% of votes cast). The ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal 2026 was also approved with 99.7% of votes cast in favor. No negative or flat metrics were reported.
- · Broker non-votes totaled 612,769 for both director elections and the Amended Plan.
- · The Amended Plan received 106,688 abstentions.
- · The 2025 Plan amendment includes shares issuable upon conversion of convertible preferred stock and prefunded warrants in the annual automatic share reserve increase calculation.
- · The company is an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.
Get daily alerts with 10 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 40 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Executive Officer Management Changes SEC
🇺🇸 More from United States
View all →June 10, 2026
US Pre-Market SEC Filings Roundup — June 10, 2026
US Pre-Market SEC Filings Roundup
June 10, 2026
US Merger & Acquisition SEC Filings — June 10, 2026
US Merger & Acquisition SEC Filings
June 10, 2026
US Corporate Board Director Changes SEC Filings — June 10, 2026
US Corporate Board Director Changes SEC Filings
June 10, 2026
US Corporate Distress Financial Stress SEC Filings — June 10, 2026
US Corporate Distress Financial Stress SEC Filings